4-ethoxy-1-(4-fluorophenyl)-1H-pyrazole-3-carboxylic acid, 95.0%, 500mg

2-(3-Chloro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

4'-(TRANS-4-PROPYLCYCLOHEXYL)-3,4-DIFLUOROBIPHENYL, 97.0%, 5g

2-(3-Bromophenyl)-1,3,4-oxadiazole, 95+%, 1g

2-Phthalimidino-glutaric acid, = 98% (HPLC), 5g

3-cycloheptyl-1H-pyrazol-5-amine, 95%, 500mg

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 4 - MWCO 12,000 to 14,000, 25 mm, 30 m, 1 Piece(s)

Methyl 4-(hydroxymethyl)-1H-pyrrole-2-carboxylate, 97%, 100mg

4-Methoxy-3-methylaniline, 99.0%, 5g

6-BROMO-3,4-DIHYDRO-2H-1-BENZOPYRAN-4-OL, 95.0%, 250mg

Ethyl 2-chloro-3-oxopropanoate, 90.0%, 10g

(4-Dodecyl-2-thienyl)trimethylstannane, >98.0%(W), 1g

2-Bromo-4-chloro-1-ethynylbenzene, 100mg